Global Cardiovascular Risk Factors Set to Surge Through 2050 Despite Better Management
A landmark GBD-based forecast reveals crude CVD burden will rise sharply through 2050, driven by high blood pressure and obesity, even as age-standardized rates improve.
Summary
Using Global Burden of Disease 2021 data, researchers projected the burden of five major modifiable cardiovascular risk factors — high systolic blood pressure, high fasting plasma glucose, high BMI, high LDL cholesterol, and tobacco use — from 2025 to 2050. While age-standardized DALY rates are expected to decline across all five risk factors, reflecting improved disease management, crude DALYs will rise substantially due to population growth and aging. High SBP will remain the dominant contributor, and high BMI will see the steepest proportional increase. These findings underscore an urgent need for targeted, region- and age-specific cardiovascular prevention strategies, particularly in low-to-middle SDI regions where the burden is rising fastest.
Detailed Summary
Cardiovascular diseases remain the world's leading cause of disability and death, responsible for 15% of all DALYs globally in 2022. Five modifiable risk factors — hypertension, dyslipidemia, dysglycemia, obesity, and tobacco use — account for more than half of the global CVD burden. This study frames these co-occurring epidemics as a 'Global Syndemic,' recognizing their shared biological mechanisms and societal drivers, and provides the most comprehensive geospatial forecast of their burden through 2050.
Researchers utilized GBD 2021 data spanning 1990–2021 across 204 countries, applying negative binomial regression — validated against Poisson and ARIMA models — to project age-standardized and crude DALY and mortality rates for each risk factor. Analyses were stratified by GBD super-region, sex, 17 age groups, and five sociodemographic index (SDI) levels, providing granular insight into where and for whom burden will be greatest.
By 2050, high systolic blood pressure will remain the most burdensome risk factor, contributing an estimated 1,694 age-standardized DALYs per 100,000 population, followed by high LDL cholesterol (658), high BMI (495), tobacco use (494), and high fasting plasma glucose (467). Although age-standardized rates decline across all five factors — signaling genuine progress in prevention and treatment — crude DALYs will surge. High SBP will add approximately 99 million additional DALYs (+44%), while high BMI will see the sharpest proportional rise, adding 44 million DALYs (+88%). Central and South Asia, Sub-Saharan Africa, and North Africa/Middle East face disproportionately worsening burdens, especially for hypertension and obesity.
The divergence between falling age-standardized rates and rising crude DALYs is a critical policy signal: population growth and demographic aging are overwhelming the gains from better cardiovascular management. Younger age groups in lower SDI regions are increasingly affected, creating an urgent need for early-life and primary prevention interventions tailored to local epidemiological profiles.
These projections serve as a roadmap for global health policymakers. Investments in hypertension control, obesity prevention infrastructure, lipid management programs, and smoking cessation — especially in rapidly urbanizing low-and-middle-income regions — will be essential to bend the crude DALY curve. The syndemic framing argues for integrated, rather than siloed, public health responses that address shared upstream determinants.
Key Findings
- High SBP will remain the top CV risk contributor in 2050 at 1,694 age-standardized DALYs per 100,000 population.
- High BMI will see the steepest proportional crude DALY rise — 88% increase (~44 million DALYs) from 2025 to 2050.
- High SBP will add the largest absolute crude DALY increase, approximately 99 million additional DALYs (+44%).
- Age-standardized DALY rates will decline for all five risk factors, reflecting improved management.
- Crude DALYs will rise across all risk factors due to population growth and aging, especially in low-SDI regions.
Methodology
Historical GBD 2021 data (1990–2021) across 204 countries were used to project DALY and mortality trends from 2025–2050 using negative binomial regression, selected after internal validation against Poisson and ARIMA models. Analyses were stratified by GBD super-region, sex, 17 age groups, and five SDI levels, with sensitivity analyses using non-linear models (logarithmic, exponential, GAM).
Study Limitations
Projections rely on historical GBD trend extrapolation and may not capture sudden epidemiological shifts, breakthrough therapies, or major policy changes. The ecological study design precludes individual-level causal inference, and GBD data quality varies by country. Other important risk factors such as dietary risk and air pollution were excluded from this analysis.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: